Clinical Trial Update: Dronabinol Opioid Sparing Evaluation (DOSE) Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Dronabinol opioid-sparing evaluation (DOSE) in chronic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

Sponsor: Daisy Pharma Opioid Venture, LLC | Conditions: Chronic Pain | Phase 2 | Status: UNKNOWN